Geneos Wealth Management’s Aphria Inc. Common Shares APHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,405
Closed -$21K 3205
2021
Q1
$21K Sell
1,405
-255
-15% -$4.13K ﹤0.01% 2074
2020
Q4
$29K Sell
1,660
-440
-21% -$2.74K ﹤0.01% 1721
2020
Q3
$8K Hold
2,100
﹤0.01% 2052
2020
Q2
$8K Sell
2,100
-550
-21% -$2.11K ﹤0.01% 2022
2020
Q1
$8K Buy
2,650
+350
+15% +$1.4K ﹤0.01% 1918
2019
Q4
$11K Sell
2,300
-500
-18% -$2.46K ﹤0.01% 1948
2019
Q3
$15K Sell
2,800
-200
-7% -$1.27K ﹤0.01% 1746
2019
Q2
$21K Buy
3,000
+2,200
+275% +$16.6K ﹤0.01% 1616
2019
Q1
$7K Hold
800
﹤0.01% 1970
2018
Q4
$4K Buy
+800
New +$6.3K ﹤0.01% 2088

Geneos Wealth Management's APHA Position: Q2 2021 in Review

Geneos Wealth Management sold out of Aphria Inc. Common Shares (APHA) in Q2 2021, closing a stake of 1,405 shares — an estimated $21K sold.

Geneos Wealth Management first reported a position in APHA in Q4 2018 and held it in 10 quarters. The position peaked at $29K in Q4 2020. 0 funds tracked by Wall St. Rank hold APHA as of Q2 2021.

  • Geneos Wealth Management reported no remaining Aphria Inc. Common Shares position as of Q2 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 1,405 Aphria Inc. Common Shares shares in Q2 2021, an estimated $21K.
  • Geneos Wealth Management first reported a position in Aphria Inc. Common Shares in Q4 2018 and held it in 10 quarters.
  • Geneos Wealth Management's Aphria Inc. Common Shares position peaked at $29K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Aphria Inc. Common Shares as of Q2 2021.

Based on Geneos Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.